4-hydroxy-2-(di-n-propylamino)indan has been researched along with apomorphine in 2 studies
| Studies (4-hydroxy-2-(di-n-propylamino)indan) | Trials (4-hydroxy-2-(di-n-propylamino)indan) | Recent Studies (post-2010) (4-hydroxy-2-(di-n-propylamino)indan) | Studies (apomorphine) | Trials (apomorphine) | Recent Studies (post-2010) (apomorphine) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 9,205 | 287 | 780 |
| Protein | Taxonomy | 4-hydroxy-2-(di-n-propylamino)indan (IC50) | apomorphine (IC50) |
|---|---|---|---|
| Tryptophan 5-hydroxylase 1 | Rattus norvegicus (Norway rat) | 0.22 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0146 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
| D | Rattus norvegicus (Norway rat) | 0.4744 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
| D(2) dopamine receptor | Bos taurus (cattle) | 0.3385 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.025 | |
| D(4) dopamine receptor | Homo sapiens (human) | 0.025 | |
| D(1B) dopamine receptor | Homo sapiens (human) | 0.025 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.025 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0813 | |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.205 | |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 1.35 | |
| D | Bos taurus (cattle) | 0.3385 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoo, VE; Bhatnagar, RK; Cannon, JG; Flynn, JR; Long, JP | 1 |
| Arvidsson, LE; Carlsson, A; Hacksell, U; Hjorth, S; Lindberg, P; Nilsson, JL; Paalzow, L; Sanchez, D; Svensson, U; Wikström, H | 1 |
2 other study(ies) available for 4-hydroxy-2-(di-n-propylamino)indan and apomorphine
| Article | Year |
|---|---|
p-Dimethoxy-substituted trans-octahydrobenzo[f]- and -[g]quinolines: synthesis and assessment of dopaminergic agonist effects.
Topics: Animals; Blood Pressure; Cats; Dopamine; Female; Haloperidol; Indicators and Reagents; Male; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Structure-Activity Relationship | 1986 |
Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity.
Topics: Animals; Behavior, Animal; Brain; Central Nervous System Agents; Dogs; Emetics; Female; Indans; Indenes; Male; Phenols; Rats; Receptors, Dopamine; Structure-Activity Relationship | 1981 |